The Latest Cardiac and Vascular News
Regional Health Care Group Selected For Commercialization in Australian Market. LAS VEGAS–(BUSINESS WIRE)–Fist Assist Devices, LLC, announces a three-year affiliation with Regional Health Care Group to commercialize and launch sales of the Fist Assist Model FA-1 device in Australia and New Zealand. The Fist Assist Model FA-1 is a wearable, […]
App-based program was co-developed by Evidation and the American College of Cardiology WASHINGTON & SAN MATEO, Calif.–(BUSINESS WIRE)–Evidation and the Department of Veterans Affairs and the Veterans Health Administration Innovation Ecosystem (VHAIE) announced today an initiative to enroll Veterans in Heart Health on Evidation—a specialized heart health program built on […]
Decorated physician brings 30+ years of experience to patients on Cape Cod HYANNIS, Mass.–(BUSINESS WIRE)–The Vascular Care Group (TVCG), a state-of-the art practice committed to the prevention, diagnosis and treatment of vascular disease, is pleased to announce that Harold J. Welch, MD, FACS, RVT, RPVI has recently joined the Hyannis, […]
SAN FRANCISCO, March 14, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Kevin King will retire from iRhythm’s Board of Directors effective April 1, 2022. Mr. King joined the iRhythm Board in […]
Philips advances precision care with new releases of HealthSuite Interoperability and Enterprise Performance Analytics – PerformanceBridge Amsterdam, the Netherlands and Orlando, Florida, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its latest introductions in analytics and interoperability solutions at the HIMSS22 Global Health Conference […]
ST. LOUIS PARK, Minn., March 14, 2022 (GLOBE NEWSWIRE) — NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, today announced the appointment of Martin B. Leon, M.D. as Executive Chair of the U.S. early feasibility study […]
Trial Evaluates FDA-Designated Breakthrough Therapy for Patients Who Lack Treatment Options MARLTON, N.J., March 14, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the first patient has been enrolled in the quadruple-blinded sham-controlled […]
PARIS, March 14, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat resistant/hard-to-treat hypertension and heart failure, announces that Stéphane Cohen, a pharmacist and ESSEC graduate, is joining the team as Director […]
Significant Progress Anticipated in 2022 with Initiation of Clinical Trial for VERVE-101 and IND-enabling Studies for ANGPTL3 Program Presentations at Upcoming Scientific Conferences to Highlight Novel Base Editing Approach and Proprietary Lipid Nanoparticle Delivery System Cash, Cash Equivalents and Marketable Securities of $360.4 Million with Cash Runway into 2024 CAMBRIDGE, Mass., […]
Forms Growth Capital Partnership to Support Expansion LAS VEGAS–(BUSINESS WIRE)–Nevada Heart and Vascular Centers, L.L.P. (“Nevada Heart & Vascular”, “NHV” or the “Company”), a leading provider of cardiac and vascular services in Southern-Nevada, announced today that it has appointed proven healthcare leader David Stillwell to serve as Chief Operating Officer […]
